Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

Congresses

ESMO Breast

2025/05/14-2025/05/17

Munich, Germany

The ESMO Breast Cancer is a congress organized by the European Society of Medical Oncology, designed for breast cancer researchers and clinicians who have a specific interest in innovation (including translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting) and care. It is a multidisciplinary meeting with a global scope, bringing together the community of experts and advocates presenting and discussing the latest ground-breaking developments in breast oncology and forging powerful new partnerships

BOOTH-2025__ESMO.jpg

Menarini Silicon Biosystems will be attending the ESMO Breast Cancer Congress 2025, an event focused on the latest developments in the science and clinical management of breast cancer.
The congress brings together oncologists, researchers, and healthcare professionals from around the world to share data, clinical experiences, and research findings aimed at improving breast cancer care.
Menarini Silicon Biosystems’s Medical Affairs team will be available at the booth throughout the congress to discuss the role of liquid biopsy technologies in advancing precision oncology for breast cancer.
To arrange a meeting during the congress, please contact us using the following link:

READ MORE

DATE

2025/05/14-2025/05/17

LOCATION

Munich, Germany

THERAPEUTIC AREAS

SPONSORSHIP

-

DOWNLOAD

-

WHERE TO FIND US

12sqm